Clinical efficacy of mifepristone and misoprostol in second trimester pregnancy termination

References

• Gissler M, Sevón T, Soimula A. Nordic statistics on induced abortions 2005. National Research and Development Centre for Welfare and Health; 2007. Statistical Summary 1/2007.
   Google Scholar
• National Research and Development Centre for Welfare and Health. Induced abortions and sterilisations; 2005. Statistical Summary 20/2006.
   Google Scholar
• Gemzell-Danielsson K, Lalitkumar S. Second trimester medical abortion with mifepristone–misoprostol and misoprostol alone: a review of methods and management. Reprod Health Matters. 2008;16:162–72.
   PubMed Web of Science ®Google Scholar
• Lalitkumar S, Bygdeman M, Gemzell-Danielsson K. Mid-trimester induced abortion: a review. Hum Reprod. 2007;13:37–52.
   Google Scholar
• Goh SE, Thong KJ. Induction of second trimester abortion (12–20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases. Contraception. 2006;73:516–19.
   PubMed Web of Science ®Google Scholar
• Ashok PW, Templeton A, Wagaarachchi PT, Flett GMM. Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception. 2004;69:51–8.
   PubMed Web of Science ®Google Scholar
• Bartley J, Baird DT. A randomised study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy. BJOG. 2002;109:1290–4.
   Web of Science ®Google Scholar
• Väyrynen W, Heikinheimo O, Nuutila M. Misoprostol-only versus mifepristone plus misoprostol in induction of labor following intrauterine fetal death. Acta Obstet Gynecol Scand. 2007;86:701–5.
   PubMed Web of Science ®Google Scholar
• Langer BR, Peter C, Firtion C, David E, Haberstich R. Second and third medical termination of pregnancy with misoprostol without mifepristone. Fetal Diagn Ther. 2004;19:266–70.
   PubMed Web of Science ®Google Scholar
• Elsheikh A, Antsaklis A, Mesogitis S, Papantoniou N, Rodolakis A, Vogas E, Use of misoprostol for the termination of second trimester pregnancies. Arch Gynecol Obstet. 2001;265:204–6.
   PubMedGoogle Scholar
• Kapp N, Borgatta L, Stubblefield P, Vragovic O, Moreno N. Mifepristone in second-trimester medical abortion a randomized controlled trial. Obstet Gynecol. 2007;10:1304–10.
   Google Scholar
• Rose SB, Shand C, Simmons A. Mifepristone- and misoprostol-induced mid-trimester termination of pregnancy: a review of 272 cases. Aust N Z J Obstet Gynaecol. 2006;46:479–85.
   PubMed Web of Science ®Google Scholar
• Nilas L, Glavind-Kristensen M, Vejborg T, Knudsen UB. One or two day mifepristone–misoprostol interval for second trimester abortion. Acta Obstet Gynecol Scand. 2007;86:1117–21.
   PubMed Web of Science ®Google Scholar
• Heikinheimo O, Suhonen S, Haukkamaa M. One- and 2-day mifepristone–misoprostol intervals are both effective in medical termination of second-trimester pregnancy. Reprod Biomed Online. 2004;8:236–9.
   PubMed Web of Science ®Google Scholar
• Tang OS, Lau WN, Chan CC, Ho PC. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy. BJOG. 2004;111:1001–5.
   PubMed Web of Science ®Google Scholar
• Dickinson JE, Evans SF. A comparison of oral misoprostol with vaginal misoprostol administration in second-trimester pregnancy termination for fetal abnormality. Obstet Gynecol. 2003;101:1294–9.
   PubMed Web of Science ®Google Scholar
• Hamoda H, Ashok PW, Flett GMM, Templeton A. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13–20 weeks gestation. Hum Reprod. 2005;20:2348–54.
   PubMed Web of Science ®Google Scholar
• Ngai SW, Tang OS, Ho PC. Randomized comparison of vaginal (200 microg every 3 h) and oral (400 microg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy. Hum Reprod. 2000;15:2205–8.
   PubMed Web of Science ®Google Scholar
• Ho PC, Blumenthal PD, Gemzell-Danielsson K, Gómez Ponce de León R, Mittal S, Tang OS. Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks. Int J Gynaecol Obstet. 2007;99:178–81.
   PubMed Web of Science ®Google Scholar
• El-Refaey H, Templeton A. Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens. Hum Reprod. 1995;10:475–8.
   PubMed Web of Science ®Google Scholar
• Heikinheimo O, Leminen R, Suhonen S. Termination of early pregnancy using flexible, low-dose mifepristone–misoprostol regimens. Contraception. 2007;76:456–60.
   PubMedGoogle Scholar
• Bracken H, Ngoc NT, Schaff E, Coyaji K, Ambardekar S, Westheimer E, Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion. Obstet Gynecol. 2007;109:895–901.
   PubMed Web of Science ®Google Scholar
• Niinimäki M, Martikainen H, Talvensaari-Mattila A. Increased risk for medical abortion failure for multiparous women. Int J Gynaecol Obstet. 2004;87:174–5.
   Google Scholar
• Ashok PW, Templeton A, Wagaarachchi PT, Flett GMM. Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. BJOG. 2002;9:1281–9.
   Google Scholar
• Feldman DM, Borgida AF, Rodis JF, Leo MV, Campbell WA. A randomized comparison of two regimens of misoprostol for second-trimester pregnancy termination. Am J Obstet Gynecol. 2003;189:710–13.
   PubMed Web of Science ®Google Scholar
• Bebbington MW, Kent N, Lim K, Gagnon A, Delisle MF, Tessier F, A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination. Am J Obstet Gynecol. 2002;187:853–7.
   PubMed Web of Science ®Google Scholar
• Tang OS, Thong KJ, Baird DT. Second trimester medical abortion with mifepristone and gemeprost: a review of 956 cases. Contraception. 2001;64:29–32.
   PubMed Web of Science ®Google Scholar
• Hamoda H, Ashok PW, Flett GMM, Templeton A. Analgesia requirements and predictors of analgesia use for women undergoing medical abortion up to 22 weeks of gestation. BJOG. 2004;111:996–1000.
   PubMed Web of Science ®Google Scholar
• Dickinson JE, Doherty DA. Factors influencing the duration of pregnancy termination with vaginal misoprostol for fetal abnormality. Prenat Diagn. 2009;29:520–4.
   PubMed Web of Science ®Google Scholar
• Dodd J, O'Brien L, Coffey J. Misoprostol for second and third trimester termination of pregnancy: a review of practice at the Women's and Children's Hospital, Adelaide, Australia. Aust N Z J Obstet Gynaecol. 2005;45:25–9.
   PubMed Web of Science ®Google Scholar